Roluperidone is a drug in development targeting primary negative symptoms in schizophrenia which binds sigma-2, 5-HT2A and alpha1a receptors. Roluperidone administered as monotherapy to patients suffering from mild to moderate negative symptoms and withdrawal ... ...

请注册登录后继续浏览